WPG Advisers
VRTX icon

WPG Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

WPG Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$147K Buy
281
+13
+5% +$6.66K 0.08% 141
2026
Q2 		$133K Buy
268
+16
+6% +$7.09K 0.08% 154
2026
Q1 		$113K Buy
252
+7
+3% +$3.26K 0.08% 132
2025
Q4 		$111K Buy
245
+9
+4% +$3.88K 0.08% 152
2025
Q3 		$92.4K Sell
236
-57
-19% -$23.8K 0.07% 177
2025
Q2 		$130K Sell
293
-3
-1% -$1.38K 0.11% 123
2025
Q1 		$144K Buy
296
+2
+0.7% +$932 0.13% 115
2024
Q4 		$118K Buy
+294
New +$136K 0.11% 160

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

WPG Advisers's VRTX Position: Q3 2026 in Review

WPG Advisers increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q3 2026, buying an estimated $6.66K and bringing the position to 281 shares worth $147K. The position accounts for 0.08% of the portfolio, ranked #141.

WPG Advisers first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 700 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • WPG Advisers held 281 shares of Vertex Pharmaceuticals worth $147K as of Q3 2026.
  • WPG Advisers bought 13 Vertex Pharmaceuticals shares in Q3 2026, an estimated $6.66K.
  • Vertex Pharmaceuticals made up 0.08% of WPG Advisers's portfolio in Q3 2026, its #141 holding.
  • WPG Advisers first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 700 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.